T. Rowe Price Investment Management
PRVA icon

T. Rowe Price Investment Management’s Privia Health PRVA Stock Holding History

T. Rowe Price Investment Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-219,058
Closed -$4.92M – 722
2025
Q1 		$4.92M Sell
219,058
-3,555,698
-94% -$82.6M ﹤0.01% 588
2024
Q4 		$73.8M Sell
3,774,756
-1,661,338
-31% -$32.9M 0.05% 340
2024
Q3 		$99M Buy
5,436,094
+81,620
+2% +$1.56M 0.06% 297
2024
Q2 		$93.1M Sell
5,354,474
-286,886
-5% -$5.08M 0.06% 299
2024
Q1 		$111M Buy
5,641,360
+921,195
+20% +$19.5M 0.07% 276
2023
Q4 		$109M Sell
4,720,165
-5,819
-0.1% -$130K 0.07% 264
2023
Q3 		$109M Sell
4,725,984
-1,766
-0% -$44.9K 0.08% 252
2023
Q2 		$123M Buy
4,727,750
+1,956,649
+71% +$51.7M 0.08% 240
2023
Q1 		$76.5M Sell
2,771,101
-22,522
-0.8% -$595K 0.05% 301
2022
Q4 		$63.4M Buy
2,793,623
+18,752
+0.7% +$522K 0.05% 324
2022
Q3 		$94.5M Buy
+2,774,871
New +$103M 0.08% 252

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management's PRVA Position: Q2 2025 in Review

T. Rowe Price Investment Management sold out of Privia Health (PRVA) in Q2 2025, closing a stake of 219,058 shares — an estimated $4.92M sold.

T. Rowe Price Investment Management first reported a position in PRVA in Q3 2022 and held it in 11 quarters. The position peaked at $123M in Q2 2023. 280 funds tracked by Wall St. Rank hold PRVA as of Q2 2025.

  • T. Rowe Price Investment Management reported no remaining Privia Health position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 219,058 Privia Health shares in Q2 2025, an estimated $4.92M.
  • T. Rowe Price Investment Management first reported a position in Privia Health in Q3 2022 and held it in 11 quarters.
  • T. Rowe Price Investment Management's Privia Health position peaked at $123M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held Privia Health as of Q2 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.